NSE: BLUEJET | BSE: 544009

Strong Performer, Getting Expensive

Download real time

856.25 -9.05 (-1.05%)

119.33% Gain from 52W Low

202.1K NSE+BSE Volume

NSE 23 Jun, 2025 3:31 PM (IST)

14,853

Market Cap

High in industry

1.4

Beta 1Year

Very High Volatility

Blue Jet Healthcare Ltd share price target and research reports

Latest analyst research reports with target prices and PDF download for BLUEJET, BSE:544009 Blue Jet Healthcare Ltd

Search Inside the pdf :

Blue Jet Healthcare Ltd

14 May 2025

856.25

-1.05%

Encouraging 2HFY25; gears up for the next leg of growth

Buy: Blue Jet Healthcare Ltd

Motilal Oswal

Blue Jet Healthcare (BLUEJET)’s 4QFY25 revenue jumped 85% YoY to INR3.4b, primarily driven by higher sales in Pharma Intermediates (PI).

Blue Jet Healthcare Ltd has gained 101.71% in the last 1 Year

Blue Jet Healthcare Ltd

19 Feb 2025

856.25

-1.05%

Blue Jet Healthcare Ltd

Buy: Blue Jet Healthcare Ltd

AUM Capital

Blue Jet Healthcare Ltd has gained 101.71% in the last 1 Year

Blue Jet Healthcare Ltd

05 Nov 2024

856.25

-1.05%

New projects to start contributing from H2FY25

Buy: Blue Jet Healthcare Ltd

ICICI Securities Limited

Blue Jet Healthcare’s (BlueJet) Q2FY25 shows a ramp-up in contrast media as ABA HCL volumes normalise; the segment should see acceleration in growth with the commissioning of intermediate for NCE MRI molecule and iodinated.

Blue Jet Healthcare Ltd has gained 101.71% in the last 1 Year

Blue Jet Healthcare Ltd

08 Aug 2024

856.25

-1.05%

Logistical delays hit revenue recognition

Buy: Blue Jet Healthcare Ltd

Target

ICICI Securities Limited

Blue Jet Healthcare’s (BlueJet) Q1FY25 print was marred by logistic delays which restricted revenue recognition despite sharp jump in production by almost 40-50%.

Blue Jet Healthcare Ltd has lost -10.22% in the last 1 Week

Blue Jet Healthcare Ltd

28 May 2024

856.25

-1.05%

Growth to ride on new products; rising pipeline efforts, a welcome step

Buy: Blue Jet Healthcare Ltd

ICICI Securities Limited

Blue Jet Healthcare’s (BlueJet) Q4FY24 print was disappointing. The company’s performance was bogged down by a few factors, but mainly – the contrast media segment being hurt from lower supplies to its largest customer, and higher recognition of change in inventory denting margins.

Blue Jet Healthcare Ltd has gained 51.75% in the last 6 Months

Blue Jet Healthcare Ltd

27 Oct 2023

856.25

-1.05%

IPO Note

IPO Subscribe: Blue Jet Healthcare Ltd

KRChoksey

Blue Jet Healthcare Ltd., founded in 1968 by Shri B.L. Arora, is a specialty pharmaceutical and healthcare ingredients and intermediate company, offering niche products, supplied to innovator and generic pharmaceutical companies as a Contract Development and Manufacturing Organization (CDMO) with specialization in contrast media intermediates and high intensity sweeteners.